Rontalizumab (RhuMab IFNalpha) 是靶向IFN-α的人源化的 IgG1 单克隆抗体。Rontalizumab 可用于系统性红斑狼疮的研究。
| 生物活性 | Rontalizumab (RhuMab IFNalpha) is a humanizedIgG1monoclonal antibody targetsIFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1]. |
| Clinical Trial | |
| 分子量 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
